Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Sequent Medical Inc. Stories

2014-04-08 08:31:00

ALISO VIEJO, Calif., April 8, 2014 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $20.0 million Series D venture capital financing, led by existing investor Delphi Ventures. All of Sequent's other existing investors participated in the financing, Domain Associates, US Venture Partners, and Versant Ventures. "We appreciate the continued support from our investor consortium as we continue to build Sequent into a leading neurovascular franchise," said Tom...

2013-11-14 08:33:46

ALISO VIEJO, Calif., and BUENOS AIRES, Argentina, Nov. 14, 2013 /PRNewswire/ -- Sequent Medical, Inc. announced today the presentation of long-term results from a retrospective study of the WEB(TM) Aneurysm Embolization System at the World Federation of Interventional Neuroradiology (WFITN) Congress. The study examined mid- and long-term aneurysm occlusion rates in 45 patients treated with the WEB across 12 European centers. In this group of patients with complex wide neck...

2013-05-20 08:26:54

ALISO VIEJO, Calif., May 20, 2013 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has received CE mark for the SL ("Single Layer") family of WEB(®) Aneurysm Embolization Devices, and has commenced a controlled release of these new models in select neurovascular centers in Europe. The SL family offers a lower profile and superior navigability that will enable physicians to treat a broader range of aneurysms with the WEB platform. The SL configurations are made possible by...

2012-12-11 08:26:38

ALISO VIEJO, Calif., Dec. 11, 2012 /PRNewswire/ -- Sequent Medical, Inc. announced today it has received CE mark for the VIA(TM) Microcatheter and is initiating commercial introduction of this new product family in select markets. The VIA will be used for delivery and deployment of Sequent's WEB® Aneurysm Embolization System, which is utilized to treat cerebral aneurysms. The VIA is currently available in two models, the VIA and the VIA PLUS. "The VIA Microcatheter provides an optimal...

2012-09-18 06:28:49

ALISO VIEJO, Calif., Sept. 18, 2012 /PRNewswire/ -- Sequent Medical, Inc. announced today the award by the U.S. Patent and Trademark Office of Patent No. 8,261,648, entitled "Braiding Mechanism and Method of Use." The company has developed proprietary MicroBraid(TM) technology to create the WEB(®) Aneurysm Embolization System. MicroBraid technology allows the fabrication of fine wire braided devices, such as the WEB, that optimize key properties of porosity, radial compliance, and...

2012-05-21 02:25:21

SANTA CLARA, Calif., May 21, 2012 /PRNewswire/ -- Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today the appointments of two new members to its Board of Directors. Thomas M. Prescott, president and CEO of Align Technology, Inc., and Thomas C. Wilder, president and CEO of Sequent Medical, Inc., are both experienced at bringing innovative medical technologies to the global marketplace. (Logo:...

2012-03-28 02:24:15

ALISO VIEJO, Calif., March 28, 2012 /PRNewswire/ -- Sequent Medical, Inc. and Inceptus Medical, LLC announced today an agreement that provides Inceptus Medical with a license to Sequent Medical's MicroBraid(TM) technology for use in select medical device applications. Sequent Medical's WEB® Aneurysm Embolization System utilizes MicroBraid technology in the treatment of cerebral aneurysms. This agreement allows Inceptus Medical to also utilize MicroBraid technology for several new product...

2012-03-06 16:43:00

ALISO VIEJO, Calif., March 6, 2012 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $26.0 million Series C venture capital financing. Delphi Ventures led the financing and was joined by existing investors Versant Ventures, US Venture Partners, and Domain Associates. James Bochnowski of Delphi Ventures will join Sequent Medical's Board of Directors. "We are fortunate to have a strong consortium of life science venture capital firms and would like to welcome both...

2010-05-13 12:22:00

ALISO VIEJO, Calif., May 13 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $15.6 million Series B venture capital financing. The financing was led by Domain Associates, joined by existing investors Versant Ventures and US Venture Partners. Nimesh Shah of Domain will join Sequent's Board of Directors. "We are privileged to have such a high caliber group of investors, and would like to welcome both Domain Associates as an investor in Sequent and Nimesh Shah as...

2010-05-13 08:00:00

ALISO VIEJO, Calif., May 13 /PRNewswire/ -- Sequent Medical, Inc. announced today that it has closed a $15.6 million Series B venture capital financing. The financing was led by Domain Associates, joined by existing investors Versant Ventures and US Venture Partners. Nimesh Shah of Domain will join Sequent's Board of Directors. "We are privileged to have such a high caliber group of investors, and would like to welcome both Domain Associates as an investor in Sequent and Nimesh Shah as...